Showing 1 - 10 of 2,606
Persistent link: https://www.econbiz.de/10011436798
Persistent link: https://www.econbiz.de/10010423401
Persistent link: https://www.econbiz.de/10010414865
Persistent link: https://www.econbiz.de/10001461562
In 2005, as the result of a World Trade Organization mandate, India began to implement product patents for pharmaceuticals that were compliant with the 1995 Trade-Related Aspects of Intellectual Property Rights (TRIPS). We combine pharmaceutical product sales data for India with a newly gathered...
Persistent link: https://www.econbiz.de/10013046165
In 2005, as the result of a World Trade Organization mandate, India began to implement product patents for pharmaceuticals that were compliant with the 1995 Trade-Related Aspects of Intellectual Property Rights (TRIPS). We combine pharmaceutical product sales data for India with a newly gathered...
Persistent link: https://www.econbiz.de/10012458117
Persistent link: https://www.econbiz.de/10000426441
The paper studies the effects of the Pfizer and Pharmacia (2003) merger on competition in the Swiss pharmaceutical market and compares the assessment of the Swiss Competition Commission (COMCO) with the post-merger market developments. We find that the merger has had a miniscule impact on the...
Persistent link: https://www.econbiz.de/10009011228
Rising costs in pharmaceutical expenditure have become a major concern for policy makers in Germany over the last years. Therefore the pharmaceutical market in Germany has been increasingly targeted by different kinds of regulations, focussing both on the supply and the demand side, using price,...
Persistent link: https://www.econbiz.de/10009492625